NOVARTIND

Novartis India Share PriceNovartis India

₹636.4
6 (0.95%)
As on 07 February, 2023 | 17:24 BSE: 500672 NSE: NOVARTIND

Novartis India Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Novartis India

Start SIP

Novartis India Share Price

  • Over 1 Month -4.22%
  • Over 3 Month -10.21%
  • Over 6 Month -10.94%
  • Over 1 Year -15.29%

Novartis India Key Statistics

P/E Ratio 29.2
PEG Ratio 0.2
Market Cap Cr 1,571
Price to Book Ratio 2.3
EPS 16.6
Dividend 1.6
Relative Strength Index 40.3
Money Flow Index 37.25
MACD Signal -9.57
Average True Range 15.36

Novartis India Investment Rating

  • Master Rating:
  • Novartis India has an operating revenue of Rs. 419.72 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 106 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Novartis India Financials
IndicatorSep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 10212198
Operating Expenses Qtr Cr 858993
Operating Profit Qtr Cr 16326
Depreciation Qtr Cr 111
Interest Qtr Cr 010
Tax Qtr Cr 34-8
Net Profit Qtr Cr 1852-23

Novartis India Technicals

EMA & SMA

Current Price
₹636.4
6 (0.95%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • 642.64
  • 50 Day
  • 656.67
  • 100 Day
  • 665.7
  • 200 Day
  • 674.02
  • 20 Day
  • 645.12
  • 50 Day
  • 661.66
  • 100 Day
  • 671.51
  • 200 Day
  • 662.02

Novartis India Resistance and Support

PIVOT
₹629.35
Resistance
First Resistance 639.46
Second Resistance 648.5
Third Resistance 658.6
RSI 40.3
MFI 37.25
MACD Single Line -9.57
MACD -10.48
Support
First Resistance 620.3
Second Resistance 610.21
Third Resistance 601.15

Novartis India Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,006 292,598 73.04
Week 5,070 318,827 62.88
1 Month 5,352 328,452 61.37
6 Month 10,434 581,675 55.75

Novartis India Result Highlights

Novartis India Synopsis

NSE-Medical-Diversified

Novartis is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 399.87 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2022. Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104.
Market Cap 1,576
Sales 420
Shares in Float 0.72
No of funds 39
Yield 1.59
Book Value 2.25
U/D Vol ratio 1.2
LTDebt / Equity
Alpha -0.07
Beta 0.52

Novartis India

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 70.68%70.68%70.68%
Mutual Funds
Insurance Companies 0.76%0.76%0.76%
Foreign Portfolio Investors 0.17%0.17%0.14%
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 23.01%23.02%22.94%
Others 5.37%5.36%5.47%

Novartis India Management

Name Designation
Mr. Christopher Snook Chairman
Mr. Sanjay Murdeshwar Vice Chairman & Mng.Director
Ms. Monaz Noble Non Exe.Non Ind.Director
Ms. Sandra Martryes Independent Director
Mr. Jai Hiremath Independent Director
Mr. Sanker Parameswaran Independent Director

Novartis India Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Novartis India Corporate Action

Date Purpose Remarks
2023-02-08 Quarterly Results
2022-11-09 Quarterly Results
2022-07-27 Quarterly Results
2022-05-19 Audited Results & Final Dividend
2022-02-10 Quarterly Results

Novartis India MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Novartis India FAQs

What is Share Price of Novartis India ?

Novartis India share price is ₹636 As on 07 February, 2023 | 17:10

What is the Market Cap of Novartis India ?

The Market Cap of Novartis India is ₹1571.3 Cr As on 07 February, 2023 | 17:10

What is the P/E ratio of Novartis India ?

The P/E ratio of Novartis India is 29.2 As on 07 February, 2023 | 17:10

What is the PB ratio of Novartis India ?

The PB ratio of Novartis India is 2.3 As on 07 February, 2023 | 17:10

Q2FY23